- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05089201
A Pilot Study to Examine the Impact of a Therapy Dog Intervention on Loneliness and Related Health Outcomes in Vulnerable Populations
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be randomly assigned (like the flip of a coin) to receive one of the following interventions:
- Animal-assisted interaction (a dog-handler team will visit them in their hospital room)
- Conversational interaction with just participants and the handler
- Treatment as usual (the regular services patients are currently receiving in the hospital)
Participation in this study will last six months. This includes the three days on which participants will receive one of the interventions described above, plus completing some questionnaires online or by phone one month and six months after the baseline visit. These questionnaires will ask questions about pet ownership, relationship with pets participants have had, loneliness, depression, anxiety, health-related quality of life, significant life events in the past year, and social supports. Approximately 180 individuals will participate in this study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- Projected to be admitted to the hospital for the upcoming four days
- Speak English
- Able to provide consent.
Exclusion Criteria:
- Fear of, or allergy to, dogs
- Documented contact precautions
- Cognitive impairment that prevents consent or completion of measures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Animal-assisted interaction (AAI)
Dogs and handlers will visit with patients for 20 minutes and discuss semi-scripted topics.
|
A dog-handler team or a handler alone will visit participants with a dog for approximately 20 minutes on 3 consecutive days during their inpatient hospital stay
|
|
Active Comparator: Conversational interaction
Handlers will have a 20 minute semi-scripted conversation with patients.
|
A handler alone will visit participants without a dog for approximately 20 minutes on 3 consecutive days during their inpatient hospital stay
|
|
No Intervention: Treatment as usual
Patients will receive treatment as usual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants enrolled
Time Frame: 2 years
|
The number of eligible patients who sigh consent forms and are randomized to a condition
|
2 years
|
|
Attrition rate
Time Frame: 30 months
|
Number of participants who do not complete the full study
|
30 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in loneliness
Time Frame: Baseline to 6 months
|
Loneliness will be assessed using the 20-item Revised (Version 3) University of California, Los Angeles Loneliness Scale (Rev University of California, Los Angeles - Loneliness Scale).
|
Baseline to 6 months
|
|
Change in depression
Time Frame: Baseline to 6 months
|
Depressive symptomology will be measured with the 10-item Center for Epidemiological Studies Depression short form (CESD-10) scale.
|
Baseline to 6 months
|
|
Change in anxiety
Time Frame: Baseline to 6 months
|
Anxiety will be measured using the 20-item scale of the State-Trait Anxiety Inventory for Adults (STAI-AD).
|
Baseline to 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nancy R. Gee, PhD, Virginia Commonwealth University
- Study Director: Lisa Townsend, PhD, Virginia Commonwealth University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HM20021567
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.